Endothelial progenitor cells in tumor angiogenesis: Another brick in the wall

Stem Cells International

Volumn 2015, Issue , 2015, Pages

  Marçola, Marina ^a   Rodrigues, Camila Eleuterio ^a  

^a UNIVERSITY OF SÃO PAULO   (Brazil)

Author keywords

[No Author keywords available]

Indexed keywords

CD14 ANTIGEN; CD45 ANTIGEN;

CELL DIFFERENTIATION; CELL HYPOXIA; ENDOTHELIAL PROGENITOR CELL; HUMAN; INTRACELLULAR SIGNALING; METASTASIS; MOLECULAR INTERACTION; NONHUMAN; PARACRINE SIGNALING; PRIORITY JOURNAL; REVIEW; TUMOR GROWTH; TUMOR VASCULARIZATION;

EID: 84929352917     PISSN: None     EISSN: 16879678     Source Type: Journal    
DOI: 10.1155/2015/832649     Document Type: Review

References (101)

1. O. K. Okamoto, "Cancer stem cell genomics: the quest for early markers of malignant progression", Expert Review of Molecular Diagnostics, vol. 9, no. 6, pp. 545-554, 2009.
2. T. Asahara, T. Murohara, A. Sullivan et al., "Isolation of putative progenitor endothelial cells for angiogenesis", Science, vol. 275, no. 5302, pp. 964-967, 1997.
3. T. Asahara, H. Masuda, T. Takahashi et al., "Bone marrow origin of endothelial progenitor cells responsible for postnatal vasculogenesis in physiological and pathological neovascularization", Circulation Research, vol. 85, no. 3, pp. 221-228, 1999.
4. T. Asahara and A. Kawamoto, "Endothelial progenitor cells for postnatal vasculogenesis", The American Journal of Physiology-Cell Physiology, vol. 287, no. 3, pp. C572-C579, 2004.
5. S. Balaji, A. King, T. M. Crombleholme, and S. G. Keswani, "The role of endothelial progenitor cells in postnatal vasculogenesis: implications for therapeutic neovascularization and wound healing", Advances in Wound Care, vol. 2, no. 6, pp. 283-295, 2013.
6. Q. Shi, S. Rafi, M. H. Wu et al., "Evidence for circulating bone marrow-derived endothelial cells", Blood, vol. 92, no. 2, pp. 362-367, 1998.
7. F. Timmermans, J. Plum, M. C. Yöder, D. A. Ingram, B. Vandekerckhove, and J. Case, "Endothelial progenitor cells: identity defned?" Journal of Cellular and Molecular Medicine, vol. 13, no. 1, pp. 87-102, 2009.
8. P. Sepúlveda, J. Martinez-León, and J. M. García-Verdugo, "Neoangiogenesis with endothelial precursors for the treatment of ischemia", Transplantation Proceedings, vol. 39, no. 7, pp. 2089-2094, 2007.
9. P. E. Szmitko, P. W. M. Fedak, R. D. Weisel, D. J. Stewart, M. J. B. Kutryk, and S. Verma, "Endothelial progenitor cells: new hope for a broken heart", Circulation, vol. 107, no. 24, pp. 3093-3100, 2003.
10. M. Grunewald, I. Avraham, Y. Dor et al., "VEGF-induced adult neovascularization: recruitment, retention, and role of accessory cells", Cell, vol. 124, no. 1, pp. 175-189, 2006.
11. C. Urbich, A. Aicher, C. Heeschen et al., "Soluble factors released by endothelial progenitor cells promote migration of endothelial cells and cardiac resident progenitor cells", Journal of Molecular and Cellular Cardiology, vol. 39, no. 5, pp. 733-742, 2005.
12. J. Rehman, J. Li, C. M. Orschell, and K. L. March, "Peripheral blood 'endothelial progenitor cells' are derived from monocyte/macrophages and secrete angiogenic growth factors", Circulation, vol. 107, no. 8, pp. 1164-1169, 2003.
13. H. Bompais, J. Chagraoui, X. Canron et al., "Human endothelial cells derived from circulating progenitors display specific functional properties compared with mature vessel wall endothelial cells", Blood, vol. 103, no. 7, pp. 2577-2584, 2004.
14. C.-H. Yoon, J. Hur, K.-W. Park et al., "Synergistic neovascularization by mixed transplantation of early endothelial progenitor cells and late outgrowth endothelial cells: the role of angiogenic cytokines and matrix metalloproteinases", Circulation, vol. 112, no. 11, pp. 1618-1627, 2005.
15. F. Timmermans, F. Van Hauwermeiren, M. De Smedt et al., "Endothelial outgrowth cells are not derived from CD133+ Cells or CD45+ hematopoietic precursors", Arteriosclerosis, Trombosis, and Vascular Biology, vol. 27, no. 7, pp. 1572-1579, 2007.
16. M. C. Yoder, L. E. Mead, D. Prater et al., "Redefning endothelial progenitor cells via clonal analysis and hematopoietic stem/progenitor cell principals", Blood, vol. 109, no. 5, pp. 1801-1809, 2007.
17. L. Wang, L. Li, F. Shojaei et al., "Endothelial and hematopoietic cell fate of human embryonic stem cells originates from primitive endothelium with hemangioblastic properties", Immunity, vol. 21, no. 1, pp. 31-41, 2004.
18. E. Oberlin, M. Tavian, I. Blazsek, and B. Péault, "Blood-forming potential of vascular endothelium in the human embryo", Development, vol. 129, no. 17, pp. 4147-4157, 2002.
19. M. A. Vodyanik, J. A. Tomson, and I. I. Slukvin, "Leukosialin (CD43) defnes hematopoietic progenitors in human embryonic stem cell differentiation cultures", Blood, vol. 108, no. 6, pp. 2095-2105, 2006.
20. L. E. Sidney, M. J. Branch, S. E. Dunphy, H. S. Dua, and A. Hopkinson, "Concise review: evidence for CD34 as a common marker for diverse progenitors", Stem Cells, vol. 32, no. 6, pp. 1380-1389, 2014.
21. J. Case, L. E. Mead, W. K. Bessler et al., "Human CD34+AC133+VEGFR-2+ cells are not endothelial progenitor cells but distinct, primitive hematopoietic progenitors", Experimental Hematology, vol. 35, no. 7, pp. 1109-1118, 2007.
22. F. Bertolini, Y. Shaked, P. Mancuso, and R. S. Kerbel, "The multifaceted circulating endothelial cell in cancer: towards marker and target identification", Nature Reviews Cancer, vol. 6, no. 11, pp. 835-845, 2006.
23. K. K. Hirschi and M. A. Goodell, "Hematopoietic, vascular and cardiac fates of bone marrow-derived stem cells", Gene Terapy, vol. 9, no. 10, pp. 648-652, 2002.
24. M. Reyes, A. Dudek, B. Jahagirdar, L. Koodie, P. H. Marker, and C. M. Verfaillie, "Origin of endothelial progenitors in human postnatal bone marrow", The Journal of Clinical Investigation, vol. 109, no. 3, pp. 337-346, 2002.
25. M. Reyes, T. Lund, T. Lenvik, D. Aguiar, L. Koodie, and C. M. Verfaillie, "Purification and ex vivo expansion of postnatal human marrow mesodermal progenitor cells", Blood, vol. 98, no. 9, pp. 2615-2625, 2001.
26. K. A. Jackson, S. M. Majka, H. Wang et al., "Regeneration of ischemic cardiac muscle and vascular endothelium by adult stem cells", The Journal of Clinical Investigation, vol. 107, no. 11, pp. 1395-1402, 2001.
27. S. Rafi and D. Lyden, "Terapeutic stem and progenitor cell transplantation for organ vascularization and regeneration", Nature Medicine, vol. 9, no. 6, pp. 702-712, 2003.
28. J. S. Russell and J. Brown, "Circulating mouse Flk1+/c-Kit+/CD45-cells function as endothelial progenitors cells (EPCs) and stimulate the growth of human tumor xenografs", Molecular Cancer, vol. 13, article 177, 2014.
29. H.-S. Hwang, Y.-S. Maeng, Y.-H. Kim, Y.-G. Kwon, Y.-W. Park, and I.-K. Kim, "Nestin expression during differentiation of fetal endothelial progenitor cells and hypoxic culture of human umbilical vein endothelial cells", Acta Obstetricia et Gynecologica Scandinavica, vol. 87, no. 6, pp. 643-651, 2008.
30. J. M. Melero-Martin and A. C. Dudley, "Concise review: vascular stem cells and tumor angiogenesis", Stem Cells, vol. 29, no. 2, pp. 163-168, 2011.
31. K. Williamson, S. E. Stringer, and M. Y. Alexander, "Endothelial progenitor cells enter the aging arena", Frontiers in Physiology, vol. 3, article 30, 2012.
32. Y. Lin, D. J. Weisdorf, A. Solovey, and R. P. Hebbel, "Origins of circulating endothelial cells and endothelial outgrowth from blood", Journal of Clinical Investigation, vol. 105, no. 1, pp. 71-77, 2000.
33. R. Gulati, D. Jevremovic, T. E. Peterson et al., "Diverse origin and function of cells with endothelial phenotype obtained from adult human blood", Circulation Research, vol. 93, no. 11, pp. 1023-1025, 2003.
34. J. Kim, Y. J. Jeon, H. E. Kim, J. M. Shin, H. M. Chung, and J. I. Chae, "Comparative proteomic analysis of endothelial cells progenitor cells derived from cord blood- and peripheral blood for cell therapy", Biomaterials, vol. 34, no. 6, pp. 1669-1685, 2013.
35. A. Aguirre, J. A. Planell, and E. Engel, "Dynamics of bone marrow-derived endothelial progenitor cell/mesenchymal stem cell interaction in co-culture and its implications in angiogenesis", Biochemical and Biophysical Research Communications, vol. 400, no. 2, pp. 284-291, 2010.
36. J. H. Liu, Z. D. Du, Z. Chen, and Z. X. He, "Whole bone marrow cell culture: a convenient protocol for the in vitro expansion of endothelial progenitor cells", Experimental and Terapeutic Medicine, vol. 8, no. 3, pp. 805-812, 2014.
37. Z. Lokmic, J. Musyoka, T. D. Hewitson, and I. A. Darby, "Hypoxia and hypoxia signaling in tissue repair and fbrosis", International Review of Cell and Molecular Biology, vol. 296, pp. 139-185, 2012.
38. S. Portal-Núñez, D. Lozano, and P. Esbrit, "Role of angiogenesis on bone formation", Histology and Histopathology, vol. 27, no. 5, pp. 559-566, 2012.
39. S. Konisti, S. Kiriakidis, and E. M. Paleolog, "Hypoxia-a key regulator of angiogenesis and infammation in rheumatoid arthritis", Nature Reviews Rheumatology, vol. 8, no. 3, pp. 153-162, 2012.
40. F. Bandello, L. Berchicci, C. La Spina, M. Battaglia Parodi, and P. Iacono, "Evidence for anti-VEGF treatment of diabetic macular edema", Ophthalmic Research, vol. 48, supplement 1, pp. 16-20, 2012.
41. L. Claesson-Welsh, "VEGF-B taken to our hearts: specific effect of VEGF-B in myocardial ischemia", Arteriosclerosis, Trombosis, and Vascular Biology, vol. 28, no. 9, pp. 1575-1576, 2008.
42. D. H. Ausprunk and J. Folkman, "Migration and proliferation of endothelial cells in preformed and newly formed blood vessels during tumor angiogenesis", Microvascular Research, vol. 14, no. I, pp. 53-65, 1977.
43. S. Käßmeyer, J. Plendl, P. Custodis, and M. Bahramsoltani, "New insights in vascular development: vasculogenesis and endothelial progenitor cells", Journal of Veterinary Medicine, Series C: Anatomia Histologia Embryologia, vol. 38, no. 1, pp. 1-II, 2009.
44. D. B. Rifin and D. Moscatelli, "Recent developments in the cell biology of basic fbroblast growth factor", The Journal of Cell Biology, vol. 109, no. 1, pp. 1-6, 1989.
45. R. F. Nicosia, S. V. Nicosia, and M. Smith, "Vascular endothelial growth factor, platelet-derived growth factor, and insulin-like growth factor-1 promote rat aortic angiogenesis in vitro", The American Journal of Pathology, vol. 145, no. 5, pp. 1023-1029, 1994.
46. Y. Takahashi, C. D. Bucana, W. Liu et al., "Platelet-derived endothelial cell growth factor in human colon cancer angiogenesis: role of infltrating cells", Journal of the National Cancer Institute, vol. 88, no. 16, pp. 1146-1151, 1996.
47. C. Suri, J. McClain, G. Turston et al., "Increased vascularization in mice overexpressing angiopoietin-1", Science, vol. 282, no. 5388, pp. 468-471, 1998.
48. M. S. Pepper, J.-D. Vassalli, L. Orci, and R. Montesano, "Biphasic effect of transforming growth factor-β1 on in vitro angiogenesis", Experimental Cell Research, vol. 204, no. 2, pp. 356-363, 1993.
49. M. E. Gleave, J.-T. Hsieh, H.-C. Wu et al., "Epidermal growth factor receptor-mediated autocrine and paracrine stimulation of human transitional cell carcinoma", Cancer Research, vol. 53, no. 21, pp. 5300-5307, 1993.
50. T. Takahashi, S. Yamaguchi, K. Chida, and M. Shibuya, "A single autophosphorylation site on KDR/Flk-1 is essential for VEGF-A-dependent activation of PLC-γ and DNA synthesis in vascular endothelial cells", EMBO Journal, vol. 20, no. 11, pp. 2768-2778, 2001.
51. C. De Vries, J. A. Escobedo, H. Ueno, K. Houck, N. Ferrara, and L. T. Williams, "The fms-like tyrosine kinase, a receptor for vascular endothelial growth factor", Science, vol. 255, no. 5047, pp. 989-991, 1992.
52. G.-H. Fong, J. Rossant, M. Gertsenstein, and M. L. Breitman, "Role of the Flt-1 receptor tyrosine kinase in regulating the assembly of vascular endothelium", Nature, vol. 376, no. 6535, pp. 66-70, 1995.
53. S. Shinkaruk, M. Bayle, G. Läin, and G. Déléris, "Vascular Endothelial Cell Growth Factor (VEGF), an emerging target for cancer chemotherapy", Current Medicinal Chemistry-Anti-Cancer Agents, vol. 3, no. 2, pp. 95-117, 2003.
54. H. Gille, J. Kowalski, L. Yu et al., "A repressor sequence in the juxtamembrane domain of Flt-1 (VEGFR-1) constitutively inhibits vascular endothelial growth factor-dependent phosphatidylinositol 3-kinase activation and endothelial cell migration", The EMBO Journal, vol. 19, no. 15, pp. 4064-4073, 2000.
55. S. Soker, S. Takashima, H. Q. Miao, G. Neufield, and M. Klagsbrun, "Neuropilin-1 is expressed by endothelial and tumor cells as an isoform-specific receptor for vascular endothelial growth factor", Cell, vol. 92, no. 6, pp. 735-745, 1998.
56. G. Neufield, O. Kessler, and Y. Herzog, "The interaction of Neuropilin-1 and Neuropilin-2 with tyrosine-kinase receptors for VEGF", in Neuropilin: From Nervous System to Vascular and Tumor Biology, vol. 515 of Advances in Experimental Medicine and Biology, pp. 81-90, Springer, New York, NY, USA, 2002.
57. A. Sakurai, C. L. Doci, and J. S. Gutkind, "Semaphorin signaling in angiogenesis, lymphangiogenesis and cancer", Cell Research, vol. 22, no. 1, pp. 23-32, 2012.
58. M. Klagsbrun, S. Takashima, and R. Mamluk, "The role of neuropilin in vascular and tumor biology", Advances in Experimental Medicine and Biology, vol. 515, pp. 33-48, 2002.
59. K. Yoshioka, K. Yoshida, H. Cui et al., "Endothelial PI3K-C2α, a class II PI3K, has an essential role in angiogenesis and vascular barrier function", Nature Medicine, vol. 18, no. 10, pp. 1560-1569, 2012.
60. M. R. Ladomery, S. J. Harper, and D. O. Bates, "Alternative splicing in angiogenesis: the vascular endothelial growth factor paradigm", Cancer Letters, vol. 249, no. 2, pp. 133-142, 2007.
61. A. Sakurai, J. Gavard, Y. Annas-Linhares et al., "Semaphorin 3E initiates antiangiogenic signaling through plexin D1 by regulating Arf6 and R-Ras", Molecular and Cellular Biology, vol. 30, no. 12, pp. 3086-3098, 2010.
62. G. Fitsialos, I. Bourget, S. Augier et al., "HIF1 transcription factor regulates laminin-332 expression and keratinocyte migration", Journal of Cell Science, vol. 121, no. 18, pp. 2992-3001, 2008.
63. B. L. Petrella, J. Lohi, and C. E. Brinckerhof, "Identification of membrane type-1 matrix metalloproteinase as a target of hypoxia-inducible factor-2 alpha in von Hippel-Lindau renal cell carcinoma", Oncogene, vol. 24, no. 6, pp. 1043-1052, 2005.
64. J.-L. Lin, M. J. Wang, D. Lee, C.-C. Liang, and S. Lin, "Hypoxiainducible factor-1α regulates matrix metalloproteinase-1 activity in human bone marrow-derived mesenchymal stem cells", FEBS Letters, vol. 582, no. 17, pp. 2615-2619, 2008.
65. D. R. Wise, P. S. Ward, J. E. S. Shay et al., "Hypoxia promotes isocitrate dehydrogenasedependent carboxylation of α-ketoglutarate to citrate to support cell growth and viability", Proceedings of the National Academy of Sciences of the United States of America, vol. 108, no. 49, pp. 19611-19616, 2011.
66. W. Petersen, T. Pufe, C. Stärke et al., "Locally applied angiogenic factors-a new therapeutic tool for meniscal repair", Annals of Anatomy, vol. 187, no. 5-6, pp. 509-519, 2005.
67. D. Liao and R. S. Johnson, "Hypoxia: a key regulator of angiogenesis in cancer", Cancer and Metastasis Reviews, vol. 26, no. 2, pp. 281-290, 2007.
68. M. W. Saif, "Anti-VEGF agents in metastatic colorectal cancer (mCRC): are they all alike?" Cancer Management and Research, vol. 5, no. 1, pp. 103-115, 2013.
69. C. Kalka, H. Masuda, T. Takahashi et al., "Transplantation of ex vivo expanded endothelial progenitor cells for therapeutic neovascularization", Proceedings of the National Academy of Sciences of the United States of America, vol. 97, no. 7, pp. 3422-3427, 2000.
70. G. P. Fadini, S. Sartore, M. Albiero et al., "Number and function of endothelial progenitor cells as a marker of severity for diabetic vasculopathy", Arteriosclerosis, Trombosis, and Vascular Biology, vol. 26, no. 9, pp. 2140-2146, 2006.
71. M. Vasa, S. Fichtlscherer, A. Aicher et al., "Number and migratory activity of circulating endothelial progenitor cells inversely correlate with risk factors for coronary artery disease", Circulation research, vol. 89, no. 1, pp. E1-E7, 2001.
72. C. Schmidt-Lucke, L. Rössig, S. Fichtlscherer et al., "Reduced number of circulating endothelial progenitor cells predicts future cardiovascular events: proof of concept for the clinical importance of endogenous vascular repair", Circulation, vol. 111, no. 22, pp. 2981-2987, 2005.
73. N. Werner, S. Kosiol, T. Schiegl et al., "Circulating endothelial progenitor cells and cardiovascular outcomes", The New England Journal of Medicine, vol. 353, no. 10, pp. 999-1007, 2005.
74. G. Chironi, L. Walch, M.-G. Pernollet et al., "Decreased number of circulating CD34+KDR+ cells in asymptomatic subjects with preclinical atherosclerosis", Atherosclerosis, vol. 191, no. 1, pp. 115-120, 2007.
75. M. B. Grant, W. S. May, S. Caballero et al., "Adult hematopoietic stem cells provide functional hemangioblast activity during retinal neovascularization", Nature Medicine, vol. 8, no. 6, pp. 607-612, 2002.
76. A. A. Kocher, M. D. Schuster, M. J. Szabolcs et al., "Neovascularization of ischemic myocardium by human bone-marrowderived angioblasts prevents cardiomyocyte apoptosis, reduces remodeling and improves cardiac function", Nature Medicine, vol. 7, no. 4, pp. 430-436, 2001.
77. J. Hur, C.-H. Yoon, H.-S. Kim et al., "Characterization of two types of endothelial progenitor cells and their different contributions to neovasculogenesis", Arteriosclerosis, Trombosis, and Vascular Biology, vol. 24, no. 2, pp. 288-293, 2004.
78. P. De La Puente, B. Muz, F. Azab, and A. K. Azab, "Cell traficking of endothelial progenitor cells in tumor progression", Clinical Cancer Research, vol. 19, no. 13, pp. 3360-3368, 2013.
79. J. E. Ohm and D. P. Carborne, "VEGF as a mediator of tumorassociated immunodefficiency", Immunologic Research, vol. 23, no. 2-3, pp. 263-272, 2001.
80. B. R. Zetter, "Angiogenesis and tumor metastasis", Annual Review of Medicine, vol. 49, pp. 407-424, 1998.
81. F. Guilak, D. M. Cohen, B. T. Estes, J. M. Gimble, W. Liedtke, and C. S. Chen, "Control of stem cell fate by physical interactions with the extracellular matrix", Cell Stem Cell, vol. 5, no. 1, pp. 17-26, 2009.
82. K. B. Vartanian, S. J. Kirkpatrick, O. J. T. McCarty, T. Q. Vu, S. R. Hanson, and M. T. Hinds, "Distinct extracellular matrix microenvironments of progenitor and carotid endothelial cells", Journal of Biomedical Materials Research Part A, vol. 91, no. 2, pp. 528-539, 2009.
83. X. Bu, Y. Yan, Z. Zhang et al., "Properties of extracellular matrixlike scafolds for the growth and differentiation of endothelial progenitor cells", Journal of Surgical Research, vol. 164, no. 1, pp. 50-57, 2010.
84. K. K. Deeb, W. Luo, A. R. Karpf et al., "Diferential vitamin D 24-hydroxylase/CYP24A1 gene promoter methylation in endothelium from benign and malignant human prostate", Epigenetics, vol. 6, no. 8, pp. 994-1000, 2011.
85. I.-W. Teng, P.-C. Hou, K.-D. Lee et al., "Targeted methylation of two tumor suppressor genes is suficient to transform mesenchymal stem cells into cancer stem/initiating cells", Cancer Research, vol. 71, no. 13, pp. 4653-4663, 2011.
86. B. Beck, G. Driessens, S. Goossens et al., "A vascular niche and a VEGF-Nrp1 loop regulate the initiation and stemness of skin tumours", Nature, vol. 478, no. 7369, pp. 399-403, 2011.
87. D. J. Nolan, A. Ciarrocchi, A. S. Mellick et al., "Bone marrowderived endothelial progenitor cells are a major determinant of nascent tumor neovascularization", Genes & Development, vol. 21, no. 12, pp. 1546-1558, 2007.
88. J. Choi, M. Nguyen, D. Lee, G. Oh, and Y. Lee, "Hypoxiainduced endothelial progenitor cell function is blunted in angiotensinogen knockout mice", Molecules and Cells, vol. 37, no. 6, pp. 487-496, 2014.
89. C.-C. Ling, K. T. P. Ng, Y. Shao et al., "Post-transplant endothelial progenitor cell mobilization via CXCL10/CXCR3 signaling promotes liver tumor growth", Journal of Hepatology, vol. 60, no. 1, pp. 103-109, 2014.
90. Q. Zhang, I. Kandic, J. T. Barfield, and M. J. Kutryk, "Coculture with late, but not early, human endothelial progenitor cells up regulates IL-1 β expression in THP-1 monocytic cells in a paracrine manner", Stem Cells International, vol. 2013, Article ID 859643, 7 pages, 2013.
91. Y. T. Shih, M. C. Wang, J. Zhou, H. H. Peng, D. Y. Lee, and J. J. Chiu, "Endothelial progenitors promote hepatocarcinoma intrahepatic metastasis through monocyte chemotactic protein-1 induction of microRNA-21", Gut, 2014.
92. B. Heissig, K. Hattori, S. Dias et al., "Recruitment of stem and progenitor cells from the bone marrow niche requires MMP-9 mediated release of Kit-ligand", Cell, vol. 109, no. 5, pp. 625-637, 2002.
93. D. J. Ceradini, A. R. Kulkarni, M. J. Callaghan et al., "Progenitor cell traficking is regulated by hypoxic gradients through HIF-1 induction of SDF-1", Nature Medicine, vol. 10, no. 8, pp. 858-864, 2004.
94. A. R. Watson, S. C. Pitchford, L. E. Reynolds et al., "Defficiency of bone marrow beta3-integrin enhances non-functional neovascularization", Journal of Pathology, vol. 220, no. 4, pp. 435-445, 2010.
95. O. Kollet, A. Spiegel, A. Peled et al., "Rapid and efficient homing of human CD34+CD38-/lowCXCR4+ stem and progenitor cells to the bone marrow and spleen of NOD/SCID and NOD/SCID/B2mnull; mice", Blood, vol. 97, no. 10, pp. 3283-3291, 2001.
96. I. Kryczek, A. Lange, P. Mottram et al., "CXCL12 and vascular endothelial growth factor synergistically induce neonaniogenisis in human ovarian cancers", Cancer Research, vol. 65, no. 2, pp. 465-472, 2005.
97. E. S. Wijelath, J. Murray, S. Rahman et al., "Novel vascular endothelial growth factor binding domains of fbronectin enhance vascular endothelial growth factor biological activity", Circulation Research, vol. 91, no. 1, pp. 25-31, 2002.
98. S. L. Bowers, C. X. Meng, M. T. Davis, and G. E. Davis, "Investigating human vascular tube morphogenesis and maturation using endothelial cell-pericyte co-cultures and a doxycyclineinducible genetic system in 3D extracellular matrices", Methods in Molecular Biology, vol. 1189, pp. 171-189, 2015.
99. A. Laurenzana, A. Biagioni, S. DAlessio et al., "Melanoma cell therapy: endothelial progenitor cells as shuttle of the MMP12 uPAR-degrading enzyme", Oncotarget, vol. 5, no. 11, pp. 3711-3727, 2014.
100. Y. I. Purwanti, C. Chen, D. H. Lam et al., "Antitumor effects of CD40 ligand-expressing endothelial progenitor cells derived from human induced pluripotent stem cells in a metastatic breast cancer model", Stem Cells Translational Medicine, vol. 3, no. 8, pp. 923-935, 2014.
101. J.-X. Zhang, C.-S. Kang, L. Shi, P. Zhao, N. Liu, and Y.-P. You, "Use of thymidine kinase gene-modified endothelial progenitor cells as a vector targeting angiogenesis in glioma gene therapy", Oncology, vol. 78, no. 2, pp. 94-102, 2010.